The Chemical Structure For The Active Ingredient Neomycin Sulfate (Maxitrol Ointment 01)
Maxitrol Ointment
Product Images NDC 0078-0771
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Maxitrol (NDC 0078-0771). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
The Chemical Structure For The Active Ingredient Polymyxin B Sulfate (Maxitrol Ointment 02)
Polymyxin-text (Maxitrol Ointment 03)
DAB stands for diamincbutyric acid.*
The Chemical Structure For The Active Ingredient Dexamethasone (Maxitrol Ointment 04)
Ndc 0078-0771-01 Maxitrol® (neomycin And Polymyxin B Sulfates And Dexamethasone Ophthalmic Ointment) Sterile 3.5 G Net Wt. Rx Only Novartis (Maxitrol Ointment 05)
Maxitrol is an ophthalmic ointment manufactured by SA Alon-Couvreur NV in Belgium and distributed by Novartis Pharmaceuticals Corporation in East Hanover, NJ. The product contains neomycin and polymyxin B and has a net weight of 3.5g. The text also includes some numerical and letter codes, as well as some unreadable characters.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
